Month: November 2019

Initiation of a Phase 2 Multicenter Study of 18F-APN-1607, a Novel Diagnostic PET Imaging Tracer for the Characterization of Tau Burden in Alzheimer’s Disease

TAIPEI, Nov. 21, 2019 /PRNewswire/ -- APRINOIA Therapeutics, Inc. announced today that it has initiated a Phase 2 multicenter, multinational...

Amendola Communications Wins “Campaign of the Year” in Business Intelligence Group 2019 Public Relations and Marketing Excellence Awards Competition

SCOTTSDALE, Ariz., Nov. 21, 2019 /PRNewswire/ -- Amendola Communications continues its award-winning momentum with today's announcement that it earned the "Campaign...

error: Content is protected !!